On January 6, the plate resumed trading: Traditional Chinese medicine became the main force of price rise! This plate 8 shares trading limit “lithium” Uncle hi again!

Today (January 6), the Shanghai and Shenzhen stock markets opened low across the board, and there was a further diving rhythm at the beginning of the market. With the rebound of track stocks, the stock index stabilized and rose. In the afternoon, the decline kinetic energy of the stock index was exhausted and pulled back at the end of the afternoon. Finally, the three major stock indexes closed on the K line with a long shadow line.

In this regard, Anxin securities mentioned that it firmly believes that we should not be pessimistic at present, and we need more patience in the bottom grinding stage. At present, the market is optimistic about the structural market, and we should be more optimistic about the index after the Spring Festival.

At the same time, the agency also said that for the evaluation of the industrial track, the overall trend of the high boom and high valuation track industry is optimistic in the medium term, but the short-term volatility will be significantly enhanced, maintaining the view of exchanging time for space.

plate:

I. concept of traditional Chinese medicine

Soochow Securities Co.Ltd(601555) said that the state strongly supports the development of traditional Chinese medicine, inherits and innovates the development of traditional Chinese medicine, which is not only a major event for the great rejuvenation of the Chinese nation, but also an inevitable requirement for building a health development model with Chinese characteristics in which traditional Chinese medicine and Western Medicine complement and develop in a coordinated manner; High quality and innovative development of drugs are the main theme in the next 5-15 years. In 14th Five-Year, the 12 full text of the plan referred to clinical value and clinical urgent need, 12 references to innovative drugs and 11 references to generic drugs. The SFA will further encourage and support the research and development of innovative drugs and generic drugs with clinical value.

China Galaxy Securities Co.Ltd(601881) securities also mentioned that national policies continue to support the development of traditional Chinese medicine industry. The traditional Chinese medicine industry is one of the key industries protected by the state. The relevant national policies actively encourage the development of the traditional Chinese medicine industry and the traditional Chinese medicine decoction piece industry. The relevant regulatory departments of various provinces have also formulated relevant policy provisions to increase support for the traditional Chinese medicine industry and related enterprises. The continuous improvement of the industry supervision system and the support of industry regulations and policies are conducive to the sustainable and healthy development of the traditional Chinese medicine industry.

The agency further analyzed that brand traditional Chinese medicine has the ability to raise prices. Recently, the ex factory prices of Beijing Tongrentang Co.Ltd(600085) Angong Niuhuang Pill and Chongqing Taiji Industry (Group) Co.Ltd(600129) Huoxiang Zhengqi oral liquid have increased, which has aroused the market’s attention to the price raising ability of brand traditional Chinese medicine. Due to the price rise of upstream raw materials, brand traditional Chinese medicine has become the main force of price rise. Brand traditional Chinese medicine has both drug and consumption attributes. It has strong independent consumption and superimposed consumption upgrading. It is basically not affected by the cost control of medical insurance. In recent years, due to the limitation of precious traditional Chinese medicine raw materials, the price has increased significantly.

In terms of investment suggestions, we are optimistic about innovative traditional Chinese medicine, brand traditional Chinese medicine with consumption attribute and scarcity attribute, and the transformation of high-quality and low-cost traditional Chinese medicine manufacturers. It is recommended that Jianmin Pharmaceutical Group Co.Ltd(600976) , the in vitro cultivation bezoar business of its affiliated subsidiary continues to rise in both volume and price under the background of shortage of natural bezoar, and the price of its OTC brand Longmu Zhuanggu granules has also been raised. It is recommended to pay attention to Zhangzhou Pientzehuang Pharmaceutical Co.Ltd(600436) , Beijing Tongrentang Co.Ltd(600085) , Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) , China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) , etc.

2、 lithium extraction from Salt Lake

Huaxin securities mentioned that the stock market at the end of the year pushed up the price of lithium salt and accelerated the upward trend. Lithium resources will still be in short supply in 2022, and enterprises mastering lithium resources will fully benefit. The lithium industry will usher in a dividend period of profit and market scale growth. Enterprises that master upstream resources and have sufficient capital and technology to expand production capacity will usher in a period of rapid development.

Citic Securities Company Limited(600030) said that recently, the market’s concern about the rapid rise of lithium price and “insufficient lithium supply” led to a significant adjustment in the lithium sector. We judge that the new global lithium supply in 2022 can meet the growth of downstream demand, and lithium will not become a hard constraint on the development of electric vehicle industry. Subject to the development cycle of mineral resources, we expect lithium to become one of the most sustainable links in the power battery industry chain. At the same time, it is expected that the catalyst and rising power of the sector will shift from “price rise” to “performance”, and the lithium sector will have strong valuation advantages and configuration value in 2022. We maintain the rating of “stronger than the big market” in the lithium industry, focus on recommending enterprises with high self-sufficiency rate of lithium mines and high degree of performance fulfillment, recommend Ganfeng Lithium Co.Ltd(002460) , Chengxin Lithium Group Co.Ltd(002240) and Qinghai Salt Lake Industry Co.Ltd(000792) , and suggest paying attention to Yongxing Special Materials Technology Co.Ltd(002756) Shenzhen Hekeda Precision Cleaning Equipment Co.Ltd(002816) manufacturing.

Huaan Securities Co.Ltd(600909) believes that the contradiction between supply and demand of lithium resources has intensified, the lithium price has accelerated upward, the lithium price center has maintained a high level, and the plate value has become prominent. At the supply side, the production of salt lakes is reduced seasonally, the release of smelting capacity is also subject to ore, and there is little increase in global supply in the medium and short term; However, the demand side lithium battery production has increased month by month. Battery factories and midstream material factories prepared goods years ago. At the same time, the midstream and downstream expanded production and scale, amplifying the demand for the upstream; The inventory of all parties in the industry is low, the contradiction between supply and demand intensifies, the spot price accelerates, the contract price of large manufacturers rises month by month, the price of individual orders jumps, and the lithium price center remains high with the support of supply and demand.

In terms of investment suggestions, focus on the leading industry segments with global competitiveness and high growth tracks represented by lithium iron phosphate and high nickel: Contemporary Amperex Technology Co.Limited(300750) , Eve Energy Co.Ltd(300014) , Jiangsu Azure Corporation(002245) , Shenzhen Dynanonic Co.Ltd(300769) , Ningbo Ronbay New Energy Technology Co.Ltd(688005) , Cngr Advanced Material Co.Ltd(300919) , Yunnan Energy New Material Co.Ltd(002812) ; It is suggested to pay attention to the links and companies that are still tight in supply and demand, can obtain excess profits of the industrial chain and continue to expand: Keda Industrial Group Co.Ltd(600499) , Chengxin Lithium Group Co.Ltd(002240) , Youngy Co.Ltd(002192) , Tianqi Lithium Corporation(002466) , Shenzhen Xfh Technology Co.Ltd(300890) .

summary of one drawing:

 

- Advertisment -